Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma.

Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma.

The safety and tolerability of sequential radioembolization-sorafenib therapy is unknown. An open-label, single arm, investigator-initiated Phase II study (NCT0071279) was conducted at four Asia-Pacific centers to evaluate the safety and efficacy of sequential radioembolization-sorafenib in patients...

Full description

Bibliographic Details
Main Authors: Pierce K H Chow, Donald Y H Poon, Maung-Win Khin, Harjit Singh, Ho-Seong Han, Anthony S W Goh, Su-Pin Choo, Hee-Kit Lai, Richard H G Lo, Kiang-Hiong Tay, Teong-Guan Lim, Mihir Gandhi, Say-Beng Tan, Khee-Chee Soo, Asia-Pacific Hepatocellular Carcinoma Trials Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3948695?pdf=render

Internet

http://europepmc.org/articles/PMC3948695?pdf=render

Similar Items